{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:55:03Z","timestamp":1754261703912},"reference-count":13,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s389688","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:55:11Z","timestamp":1668646511000},"page":"3803-3809","source":"Crossref","is-referenced-by-count":2,"title":["Real-World Use of Loteprednol Etabonate 0.5%\/Tobramycin 0.3% Ophthalmic Suspension for the Treatment of Ocular Surface Inflammatory Conditions"],"prefix":"10.2147","volume":"Volume 16","author":[{"given":"James E","family":"Deom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Kannarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40123-013-0020-5","volume":"2","author":"Pleyer","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"ref3","unstructured":"Zylet (loteprednol etabonate and tobramycin ophthalmic suspension 0.5%\/0.3%) [package insert]. Rochester, NY: Bausch & Lomb Incorporated; 2021."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0960-0760(91)90120-T","volume":"38","author":"Druzgala","year":"1991","journal-title":"J Steroid Biochem Molec Biol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/14656566.2018.1439920","volume":"19","author":"Comstock","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12325-016-0315-8","volume":"33","author":"Sheppard","year":"2016","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s40123-021-00401-x","volume":"10","author":"Mah","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"ref8","first-page":"414","volume":"62","author":"Deom","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1185\/030079908X253898","volume":"24","author":"White","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/09273948.2015.1115879","volume":"25","author":"Comstock","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"ref11","first-page":"1","volume":"38","author":"Chen","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.ophtha.2014.02.009","volume":"121","author":"Khawaja","year":"2014","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/exer.1999.0786","volume":"70","author":"Linden","year":"2000","journal-title":"Exp Eye Res"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=85496","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=85496","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:55:17Z","timestamp":1668646517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-use-of-loteprednol-etabonate-05tobramycin-03-ophthalmic-sus-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":13,"URL":"https:\/\/doi.org\/10.2147\/opth.s389688","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}